Vinge has advised Amasten Fastighets AB (“Amasten”), a real estate company, in connection with a directed share issue whereby Amasten receives SEK 500 million in issue proceeds.
Vinge has advised Azelio, a public Swedish company specialising in thermal energy storage with dispatchable and low-cost Stirling-based electricity and heat production, in connection with a directed share issue whereby Azelio raises SEK 270 million in issue proceeds before transaction costs.
Vinge has advised Nabo, a group that offers administration and management services to housing associations, on its acquisition of Örehus Fastighetsförvaltning Aktiebolag.
Vinge has acted for Ellevio in connection with its acquisition of the shares in Elektra Nät AB, an electricity distribution network operator, and AB Helsinge Elhandel, an energy supplier, from AB Edsbyns Elverk (publ).
Vinge has advised Cellink AB, listed on Nasdaq Stockholm, in connection with the acquisition of all shares in Scienion Ag. Scienion is a life science company which focuses on precision dimensioning technology.
Vinge has advised Cellink in connection with directed new issues of shares of approximately 5.9 million class B shares which will generate MSEK 946 for Cellink.
Vinge advises Calliditas Therapeutics, a specialty pharmaceutical company listed on Nasdaq Stockholm and on The Nasdaq Global Select Market in the US, in connection with its acquisition of a controlling interest of 62.7% of the French company Genkyotex SA, a leader in NOX inhibition therapies and listed on Euronext Paris and Euronext Brussels.
The board of directors of Samhällsbyggnadsbolaget i Norden has, on the basis of an authorization granted by the annual general meeting, resolved on a directed issue of class D shares and a directed issue of subordinated convertibles mandatorily convertible into class B shares, whereby the company raises proceeds of SEK 3.4 billion before issue costs.
